ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ)

$2.12 0.02 (0.9524%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 68

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ) News Sources

Allogene Therapeutics Announces Participation in Upcoming Investor Conferences

26-05-2026

yahoo.com

Allogene Therapeutics Announces Planned CEO Succession

28-05-2026

yahoo.com

Allogene Therapeutics, Inc. (ALLO) A Top Penny Stock to Buy on Robust CAR T-Cell Portfolio

07-06-2026

yahoo.com

Why Is Allogene Therapeutics (ALLO) Down 12.2% Since Last Earnings Report?

12-06-2026

yahoo.com

How Allogene Therapeutics (ALLO) Is Expanding Its Off-the-Shelf CAR T Platform Across Cancer and Autoimmune Disease

17-06-2026

yahoo.com

Allogene Therapeutics (ALLO) Stock Gets Fair Value Boost After Split Analyst Revisions

28-06-2026

yahoo.com

Kyverna Therapeutics Sinks 13%: Here’s Why

10-07-2026

247wallst.com

Allogene Therapeutics Announces Journal of Clinical Oncology Publication of Phase 1 Results of ALLO-316 Highlighting First Durable Remissions Following Allogeneic CAR T for Treatment of Metastatic Solid Tumors

15-07-2026

yahoo.com

Allogene Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Cemacabtagene Ansegedleucel (Cema-Cel) as First-Line Consolidation Therapy for Large B-Cell Lymphoma

29-07-2026

yahoo.com

Allogene Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update

04-08-2026

yahoo.com

ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ) Sentiment Trend

0 25 50 75 100 70 87 85 2 91 85 45 62 79 74 26-05-2026 28-05-2026 07-06-2026 12-06-2026 17-06-2026 28-06-2026 10-07-2026 15-07-2026 29-07-2026 04-08-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ) FAQs

toggle

What is the current price of ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ)?

The current price of ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ) is $2.12.


toggle

ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ) absolute price change since previous trading day?

The absolute price change of ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ) since the previous trading day is $0.02.


toggle

ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ) percentage price change since previous trading day?

The percentage price change of ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ) since the previous trading day is 0.9524%.


toggle

What is the most recent average sentiment score for ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ)?

The most recent average sentiment score for ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ) is 68 out of 100.


toggle

What is the most recent average sentiment for ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ)?

The most recent sentiment for ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ) is .


SEC-8K** Filing Available For ALLOGENE THERAPEUTICS INC (ALLO:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.